Screener
Bionano Genomics, Inc. BNGO Q2 2026 earnings
Reported August 10, 2026 · After market close
Revenue$8.2MBeat by $619.0K
EPS-$0.64Beat by $0.03
Revenue estimate$7.6M
EPS estimate-$0.67
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$8.4M
EPS estimate-$0.45
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Bionano Genomics, Inc. report Q2 2026 earnings?
- Bionano Genomics, Inc. (BNGO) reported Q2 2026 earnings on August 10, 2026 after market close.
- What were Bionano Genomics, Inc.'s Q2 2026 revenue and EPS?
- Bionano Genomics, Inc. reported revenue of $8.2M and eps of $-0.64 for Q2 2026.
- Did Bionano Genomics, Inc. beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $7.6M by $619.0K. EPS beat the consensus estimate of $-0.67 by $0.03.
- How did Bionano Genomics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 21.4% from $6.7M a year earlier and eps grew 67.8% from $-1.99.
- Where can I find Bionano Genomics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001411690-26-000043) and the 10-Q periodic report (0001411690-26-000044) directly on SEC EDGAR. The filing index links above go to sec.gov.
